Lawmakers Open to New Ideas to Spur Drug, Device Innovation

Nov. 30, 2017, 8:44 PM

Members of a key House panel indicated they’re open to additional legislative action if necessary to speed new medicines to patients.

Rep. Michael C. Burgess (R-Texas), chairman of the Energy and Commerce health subcommittee, and Rep. Diana DeGette (D-Colo.) made their remarks exactly one year after the House passed 21st Century Cures, a broad biomedical research bill to spur new drugs and devices. The Cures bill became law Dec. 13, 2016 (Pub. L. 114-255), and Burgess’s subcommittee heard Nov. 30 from the heads of the National Institutes of Health and the Food and Drug Administration on how the ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.